Literature DB >> 11907184

In utero ethanol suppresses cerebellar activator protein-1 and nuclear factor-kappa B transcriptional activation in a rat fetal alcohol syndrome model.

George K Acquaah-Mensah1, James P Kehrer, Steven W Leslie.   

Abstract

A model of fetal alcohol syndrome was used to investigate prenatal ethanol effects on cerebellar transcription factors. Pregnant Sprague-Dawley rats were divided into three treatment groups: ethanol-exposed (E), calorically matched pair-fed (PF), and freely fed ad libitum (AL) groups. Ethanol exposure was stopped 2 days before parturition. The DNA binding in neonatal cerebella of the redox-sensitive transcription factors nuclear factor-kappa B (NF-kappa B) and activator protein-1 (AP-1) were determined by electrophoretic mobility shift assays. On the first postnatal day (PD1), there was decreased activation of these transcription factors in the E group relative to the control groups. The PD1 transcriptional effects were reversed as the neonate underwent development without further ethanol exposure. Western blot studies showed no corresponding decreases in protein amounts of both AP-1 and NF-kappa B components on PD1. Postnatal glutathione levels and catalase activity, as measures of oxidative stress hypothesized to be a probable cause of the transcriptional effects, showed no statistically significant effects attributable to ethanol. Examination of prenatal cerebella on embryonic day 20 (EM20), a time during ethanol exposure, showed DNA-binding trends similar to those of PD1. EM20 Western blot studies showed decreases in the levels of the active form of glycogen synthase kinase-3 (GSK-3). GSK-3 inhibition was reversed by PD1. Blocking of GSK-3 activity with gestational dietary lithium diminished both AP-1 and NF-kappa B DNA binding. Thus, prenatal ethanol exposure has the effect of diminishing pro-survival transcriptional activation, an effect possibly mediated by changes in GSK-3 activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11907184     DOI: 10.1124/jpet.301.1.277

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  8 in total

1.  Transcriptome-Wide Regulation of Key Developmental Pathways in the Mouse Neural Tube by Prenatal Alcohol Exposure.

Authors:  Karen E Boschen; Travis S Ptacek; Jeremy M Simon; Scott E Parnell
Journal:  Alcohol Clin Exp Res       Date:  2020-07-01       Impact factor: 3.455

2.  The expression of antioxidant enzymes in a mouse model of fetal alcohol syndrome.

Authors:  Nathan Drever; Huaizhi Yin; Talar Kechichian; Maged Costantine; Monica Longo; George R Saade; Egle Bytautiene
Journal:  Am J Obstet Gynecol       Date:  2012-01-13       Impact factor: 8.661

Review 3.  Role of central nervous system insulin resistance in fetal alcohol spectrum disorders.

Authors:  Suzanne M de la Monte; Jack R Wands
Journal:  J Popul Ther Clin Pharmacol       Date:  2010-10-26

4.  Diabetes-induced fetal growth retardation is associated with suppression of NF-kappaB activity in embryos.

Authors:  Keren Mammon; Rotem Keshet; Shoshana Savion; Olga Pekar; Zeev Zaslavsky; Amos Fein; Vladimir Toder; Arkady Torchinsky
Journal:  Rev Diabet Stud       Date:  2005-05-10

Review 5.  The Genetics of Fetal Alcohol Spectrum Disorders.

Authors:  Johann K Eberhart; Scott E Parnell
Journal:  Alcohol Clin Exp Res       Date:  2016-04-28       Impact factor: 3.455

6.  Ethanol inhibition of aspartyl-asparaginyl-beta-hydroxylase in fetal alcohol spectrum disorder: potential link to the impairments in central nervous system neuronal migration.

Authors:  Suzanne M de la Monte; Ming Tong; Rolf I Carlson; Jade J Carter; Lisa Longato; Elizabeth Silbermann; Jack R Wands
Journal:  Alcohol       Date:  2009-05       Impact factor: 2.405

7.  Genetic aspects of behavioral neurotoxicology.

Authors:  Edward D Levin; Michael Aschner; Ulrike Heberlein; Douglas Ruden; Kathleen A Welsh-Bohmer; Selena Bartlett; Karen Berger; Lang Chen; Ammon B Corl; Donnie Eddins; Rachael French; Kathleen M Hayden; Kirsten Helmcke; Helmut V B Hirsch; Elwood Linney; Greg Lnenicka; Grier P Page; Debra Possidente; Bernard Possidente; Annette Kirshner
Journal:  Neurotoxicology       Date:  2009-07-30       Impact factor: 4.294

Review 8.  Neuroprotective effects of psychotropic drugs in Huntington's disease.

Authors:  Edward C Lauterbach
Journal:  Int J Mol Sci       Date:  2013-11-15       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.